|Committee Member||Employment||Consultant||Speakers Bureau||Ownership/Partnership/Principal||Personal Research||Institutional, Organizational, or Other Financial Benefit||Expert Witness|
|Gordon F. Tomaselli, Chair||Johns Hopkins School of Medicine—Chief of Cardiology||None||None||None||None||None||None|
|Kenneth W. Mahaffey, Vice Chair||Stanford Center for Clinical Research—Director; Stanford Department of Medicine—Vice-Chair of Clinical Research, Department of Medicine Stanford Center for Clinical Research||None||None||None||None|
|Adam Cuker||University of Pennsylvania—Assistant Professor and Pathology & Laboratory Medicine||None||None||None||None||None||None|
|Paul P. Dobesh||University of Nebraska Medical Center—AQ Cardiology Professor of Pharmacy Practice, College of Pharmacy||None||None||None||None||None|
|John U. Doherty||Jefferson Medical College of Thomas Jefferson University—Professor of Medicine||None||None||None||None||None||None|
|John W. Eikelboom||McMaster University—Associate Director, Department of Medicine||None||None||None||None|
|Roberta Florido||Johns Hopkins School of Medicine—Fellow in Cardiovascular Medicine||None||None||None||None||None||None|
|William Hucker||Massachusetts General Hospital—Fellow in Cardiovascular Medicine||None||None||None||None||None||None|
|Roxana Mehran||Mount Sinai Medical Center—Professor of Medicine||None||None||None||None|
|Steven R. Messé||University of Pennsylvania—Associate Professor of Neurology||None||None||None||None||None||None|
|Charles V. Pollack, Jr.||Thomas Jefferson University Hospital—Professor of Emergency Medicine and Associate Provost||None||None||None||None|
|Fatima Rodriguez||Stanford University Medical Center–Fellow in Cardiovascular Medicine||None||None||None||None||None||None|
|Ravindra Sarode||University of Texas Southwestern—Professor of Pathology, Chief of Pathology and Medical Director of Clinical Laboratory Services, UT Southwestern Medical Center, and Director, Transfusion Medicine and Hemostasis||None||None||None||None||None|
|Deborah Siegal||McMaster University—Clinical Scholar, Division of Hematology and Thromboembolism||None||None||None||None|
|Barbara S. Wiggins||Medical University of South Carolina—Clinical Pharmacy Specialist, Cardiology Department of Pharmacy Services||None||None||None||None||None||None|
This table represents the relationships of committee members with industry and other entities that were determined to be relevant to this document. These relationships were reviewed and updated in conjunction with all meetings and/or conference calls of the writing committee during the document development process. The table does not necessarily reflect relationships with industry at the time of publication. A person is deemed to have a significant interest in a business if the interest represents ownership of ≥5% of the voting stock or share of the business entity, or ownership of ≥$5,000 of the fair market value of the business entity; or if funds received by the person from the business entity exceed 5% of the person’s gross income for the previous year. Relationships that exist with no financial benefit are also included for the purpose of transparency. Relationships in this table are modest unless otherwise noted.
According to the ACC, a person has a relevant relationship IF: a) the relationship or interest relates to the same or similar subject matter, intellectual property or asset, topic, or issue addressed in the document; or b) the company/entity (with whom the relationship exists) makes a drug, drug class, or device addressed in the document or makes a competing drug or device addressed in the document; or c) the person or a member of the person’s household, has a reasonable potential for financial, professional or other personal gain or loss as a result of the issues/content addressed in the document.
ACC = American College of Cardiology; SCAI = Society for Cardiac Angiography and Interventions.